NCT07481331

Brief Summary

The goal of this study is to develop a new scale for assessing prolonged pain, dedicated to extremely premature infants born before 27 weeks of gestation, adapted to their particular ways of expressing pain and discomfort, which will be called the EDEX (Extremely Premature Infant Pain Assessment Scale). This scale will take into account the level of development of extremely premature infants, recognizing that the perception and manifestations of pain vary according to gestational age. It was chosen to develop a specific pain assessment scale for preterm infants born before 27 weeks of gestation, in line with their level of development and their relatively homogeneous manifestations in this population. This population, which is the most immature, is particularly fragile and sensitive to its environment and the care provided. Pain manifestations are the most subtle, vegetative reactions are very present, and the motor system is still underdeveloped, linked to low muscle tone. It is with this category of patients that the nursing staff encounter the most difficulty in assessing pain and discomfort based on the EDIN scale. After creating the new EDEX scale during the first phase of the DOU-PREMA study, both scales (EDIN and EDEX) will be administered to the same pool of extremely premature infants during the second phase of the DOU-PRÉMA study in order to assess the correlation between the two scales. The main hypothesis is that EDIN and EDEX scores will not be correlated, as the EDIN does not appear to be suitable for extremely premature infants in routine practice. if the hypothesis is confirmed, a multicenter psychometric validation of the EDEX scale will then be considered in a future study. The study is a monocentric, non-interventional observational study conducted in the neonatal intensive care unit (NICU) of the University Hospital of Reunion Island (Site Nord). It is designed as a preliminary step toward the psychometric validation of a newly developed behavioral pain and discomfort assessment scale for extremely preterm infants (\<27 weeks' gestational age), named EDEX. The study includes two sequential phases:

  1. 1.a developmental phase dedicated to the creation of the EDEX scale : This stage is based on the production of videos of premature extreme in order to ajust the provisional scale define during a multidisciplinary meeting.
  2. 2.a cross-sectional observational phase comparing EDEX with the EDIN scale in the same population.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P25-P50 for all trials

Timeline
19mo left

Started Apr 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Apr 2026Feb 2028

First Submitted

Initial submission to the registry

March 9, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

March 18, 2026

Completed
14 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2028

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2028

Last Updated

March 18, 2026

Status Verified

March 1, 2026

Enrollment Period

1.8 years

First QC Date

March 9, 2026

Last Update Submit

March 16, 2026

Conditions

Keywords

pain and discomfort scaleextremely premature infants

Outcome Measures

Primary Outcomes (1)

  • Correlation between scores on the new EDEX pain assessment scale and scores obtained with the EDIN

    The correlation between EDIN and EDEX scores will be assessed using Spearman's coefficient.

    at baseline

Secondary Outcomes (5)

  • Distribution of scores obtained in the EDIN and EDEX

    through study completion, an average of 18 months

  • Description of the EDEX adaptation procedure.

    through study completion, an average of 18 months

  • Description of the difficulties and quality of the EDEX adaptation, by the members of the working group

    through study completion, an average of 18 months

  • Assessment of paramedics' satisfaction with EDEX

    through study completion, an average of 18 months

  • Comparison of EDIN and EDEX scores before and after taking painkillers (sensitivity to change)

    through study completion, an average of 18 months

Study Arms (2)

EP - phase 1

Production of observation videos at 8 Extremely Premature infants

EP - Phase 2

Assessment of pain and discomfort in 60 extremely premature infants using EDIN and EDEX scales

Eligibility Criteria

AgeUp to 27 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Extremely premature infants(\< 27 weeks of amenorrhea) hospitalised in neonatal intensive care at University Hospital Centre of Reunion Island

You may qualify if:

  • Extremely premature infants:
  • born before 27 weeks of gestation, and aged no more than 26 weeks of amenorrhea + 6 days in corrected age,
  • from 48 hours of life,
  • hospitalised in neonatal intensive care,
  • for whom at least one of the two legal guardians has given their consent.

You may not qualify if:

  • Extreme premature infants:
  • whose clinical condition is critical with a risk of imminent death,
  • with major brain damage (HIV 4) or major brain malformations,
  • deeply sedated or paralyzed with no spontaneous reactions,
  • whose parents are both minors.
  • who are not already participating in another study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Fleur BRIGNANO

    University Hospital Centre of Reunion Island

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 9, 2026

First Posted

March 18, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

February 1, 2028

Study Completion (Estimated)

February 1, 2028

Last Updated

March 18, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share